News & Publications
Stay in the know about our company, science and our aspiration to use gene therapy to restore vision and prevent blindness.
News & Press Releases
News
November 28, 2023
News
November 6, 2023
Publications
Presentations
November 4, 2023
Presentations
October 25, 2023
Presentations
October 25, 2023
Presentations
May 19, 2023
Presentations
May 18, 2023
Investors
We’re pioneering innovation in the field of gene therapy. For our lead therapy ADVM-022, we are excited to see the potential for a single intravitreal injection to extend the treatment benefit from weeks to years in patients with wet AMD – even those who may have previously required frequent anti-VEGF injections. Our mission is to establish ocular gene therapy as a new standard of care for debilitating ocular diseases.
